Garrett Gerald 4
4 · Marker Therapeutics, Inc. · Filed Mar 12, 2020
Insider Transaction Report
Form 4
Garrett Gerald
Vice President, Clinical Ops.
Transactions
- Award
Employee Stock Option (Right to Buy)
2020-03-10+1,700→ 1,700 totalExercise: $2.12Exp: 2030-03-10→ Common Stock (1,700 underlying) - Award
Employee Stock Option (Right to Buy)
2020-03-10+38,300→ 38,300 totalExercise: $2.12Exp: 2030-03-10→ Common Stock (38,300 underlying)
Footnotes (2)
- [F1]Represents a bonus for 2019 performance granted under the Company's 2014 Omnibus Stock Ownership Plan. This option vests in equal monthly installments over a four year period commencing on April 10, 2020 subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date.
- [F2]This option vests in equal monthly installments over a four year period commencing on April 10, 2020 subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date.